Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
461
Views
79
CrossRef citations to date
0
Altmetric
Review

Strategies of temozolomide in future glioblastoma treatment

Chooi Yeng LeeSchool of Pharmacy, Monash University Malaysia, Selangor, MalaysiaCorrespondence[email protected]
Pages 265-270 | Published online: 09 Jan 2017

Citations (79)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Wei Chen, Ning Wang & Minxue Lian. (2021) CircRNA circPTK2 Might Suppress Cancer Cell Invasion and Migration of Glioblastoma by Inhibiting miR-23a Maturation. Neuropsychiatric Disease and Treatment 17, pages 2767-2774.
Read now
Nadhem Aissani, Ferdaous Albouchi & Hichem Sebai. (2021) Anticancer Effect in Human Glioblastoma and Antioxidant Activity of Petroselinum crispum L. Methanol Extract. Nutrition and Cancer 73:11-12, pages 2605-2613.
Read now
Divyaansh Raj, Pranjal Agrawal, Hallie Gaitsch, Elizabeth Wicks & Betty Tyler. (2021) Pharmacological strategies for improving the prognosis of glioblastoma. Expert Opinion on Pharmacotherapy 22:15, pages 2019-2031.
Read now
Yadollah Omidi, Nazanin Kianinejad, Young Kwon & Hossein Omidian. (2021) Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier. Expert Review of Clinical Pharmacology 14:3, pages 357-381.
Read now
Jiwei Wang, Qichao Qi, Wenjing Zhou, Zichao Feng, Bin Huang, Anjing Chen, Di Zhang, Wenjie Li, Qing Zhang, Zheng Jiang, Rolf Bjerkvig, Lars Prestegarden, Frits Thorsen, Xinyu Wang, Xingang Li & Jian Wang. (2018) Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy. Autophagy 14:11, pages 2007-2022.
Read now

Articles from other publishers (74)

Mahsa Iraji, Ali Khaleghian, Rahime Eshaghi Malekshah, Masoud Abbasi & Dorna Basir. (2023) Syntheses, characterization of Imidazo[4,5-f][1,10]phenanthroline derivative and As (III) complex, In vitro evaluation, the determine of apoptosis mechanism; theoretical and quantum studies. Journal of Drug Delivery Science and Technology 85, pages 104528.
Crossref
Muhammad Ikram & Sufian Rasheed. (2023) Genetics of Dravet Syndrome and its Targeted Therapy by Nanomedicine: A Roadmap for Future Treatment of Drug Resistant Seizures. Current Molecular Pharmacology 16:4, pages 475-493.
Crossref
Shima Ghazarian, Zahra Kalantar & Seyed Majid Hashemianzadeh. (2023) An exploration of efficiency of proposed drug delivery system including BNNT, C48N12, and TMZ in treating of glioblastoma through classical molecular dynamics. Journal of Molecular Liquids 379, pages 121625.
Crossref
Yuan Fu, Hongxia Dong & Xinzhong Ruan. (2023) Comparison of multi-cycle and standard-cycle temozolomide chemotherapies in patients with glioblastoma undergoing surgery and successive radiotherapy. Interdisciplinary Neurosurgery 32, pages 101736.
Crossref
Raghavi Kakarla, Kimberly Yacoub, Rebecca L Bearden, Aimin Zhou, Sanjib Mukherjee, Frank Y. Shan & Baochuan Guo. (2023) Development and validation of a liquid chromatography‐tandem mass spectrometry method for the determination of temozolomide in mouse brain tissue. SEPARATION SCIENCE PLUS 6:4.
Crossref
Qingchun Lei, Yongmin Yang, Wenhui Zhou, Wenwen Liu, Yixin Li, Nanchang Qi, Qiangfeng Li, Zhonghui Wen, Lei Ding, Xiaobin Huang, Yu Li & Jin Wu. (2023) MicroRNA-based therapy for glioblastoma: Opportunities and challenges. European Journal of Pharmacology 938, pages 175388.
Crossref
Mostafa Torabi, Fatemeh Yaghoobi, Reza Karimi Shervedani, Amirhosein Kefayat, Fatemeh Ghahremani & Parisa Rashidiyan Harsini. (2022) Mn(II) & Gd(III) deferrioxamine complex contrast agents & temozolomide cancer prodrug immobilized on folic acid targeted graphene/polyacrylic acid nanocarrier: MRI efficiency, drug stability & interactions with cancer cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects 652, pages 129797.
Crossref
Yossi Nishri, Maayan Vatarescu, Ishai Luz, Lior Epstein, Mirta Dumančić, Sara Del Mare, Amit Shai, Michael Schmidt, Lisa Deutsch, Robert B. Den, Itzhak Kelson, Yona Keisari, Lior Arazi, Tomer Cooks & Vered Domankevich. (2022) Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts. Frontiers in Oncology 12.
Crossref
Mohammad Algahtani, Umamaheswari Natarajan, Khalid Alhazzani, Ali Alaseem & Appu Rathinavelu. (2022) Evaluation of anti-angiogenic agent F16 for targeting glioblastoma xenograft tumors. Cancer Genetics 264-265, pages 71-89.
Crossref
Saikat Ghosh, Pie Huda, Nicholas L. Fletcher, Christopher B. Howard, Bradley Walsh, Douglas Campbell, Mark B. Pinkham & Kristofer J. Thurecht. (2022) Antibody-Based Formats to Target Glioblastoma: Overcoming Barriers to Protein Drug Delivery. Molecular Pharmaceutics 19:5, pages 1233-1247.
Crossref
Amir Barzegar Behrooz, Reza Vazifehmand, Asilah Ahmad Tajudin, Mas Jaffri Masarudin, Zamberi Sekawi, Malihe Masomian & Amir Syahir. (2021) Tailoring drug co-delivery nanosystem for mitigating U-87 stem cells drug resistance. Drug Delivery and Translational Research 12:5, pages 1253-1269.
Crossref
Roseli da S. Soares, Talita de S. Laurentino, Camila T. da Silva, Jéssica D. Gonçalves, Antonio M. Lerario, Suely K. N. Marie, Sueli M. Oba-Shinjo & Miriam G. Jasiulionis. (2022) Cellular Model of Malignant Transformation of Primary Human Astrocytes Induced by Deadhesion/Readhesion Cycles. International Journal of Molecular Sciences 23:9, pages 4471.
Crossref
Daisy S. Precilla, Shreyas S. Kuduvalli, Mugilarasi Purushothaman, Parthiban Marimuthu, Arumugam Ramachandran Muralidharan & Thirugnanasambandham Sivasubramanian Anitha. (2022) Wnt/β-catenin Antagonists: Exploring New Avenues to Trigger Old Drugs in Alleviating Glioblastoma Multiforme. Current Molecular Pharmacology 15:2, pages 338-360.
Crossref
Yao-Min Li, Li-Hui Meng, Yan-Ru Hu, Tian-Tian Zhang, Zheng-Nan Su, Zhi-Yuan Ouyang, Wen-Chao Li, Jiang-Ling Wan & Qing-Zhi Wu. (2022) Suppression mechanisms on proliferation of glioma U251 cells by FePt nanoparticles through intracellular oxidative stress. Rare Metals 41:4, pages 1202-1209.
Crossref
Qingxin Song, Shanxin Peng, Fengyuan Che & Xiaosong Zhu. (2022) Artesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells. Journal of Pharmacological Sciences 148:3, pages 300-306.
Crossref
I.-Tsang Chiang, Yu-Chang Liu, Hua-Shan Liu, Ahmed Atef Ahmed Ali, Szu-Yi Chou, Tsung-I. Hsu & Fei-Ting Hsu. (2022) Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma. Neurotherapeutics 19:2, pages 616-634.
Crossref
Víctor Chavarria, Emma Ortiz-Islas, Alelí Salazar, Verónica Pérez-de la Cruz, Alejandra Espinosa-Bonilla, Rubén Figueroa, Alma Ortíz-Plata, Julio Sotelo, Francisco Javier Sánchez-García & Benjamín Pineda. (2022) Lactate-Loaded Nanoparticles Induce Glioma Cytotoxicity and Increase the Survival of Rats Bearing Malignant Glioma Brain Tumor. Pharmaceutics 14:2, pages 327.
Crossref
Smruti Rekha Rout, Gowtham Kenguva, Vanshikha Singh, Sushama Talegaonkar, Prashant Kesharwani & Rambabu Dandela. 2022. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases 273 295 .
Jordina Rincon-Torroella, Harmon Khela, Anya Bettegowda & Chetan Bettegowda. (2021) Biomarkers and focused ultrasound: the future of liquid biopsy for brain tumor patients. Journal of Neuro-Oncology 156:1, pages 33-48.
Crossref
Radhika Saraf, Shaghayegh Agah, Aniruddha Datta & Xiaoqian Jiang. (2021) Drug target ranking for glioblastoma multiforme. BMC Biomedical Engineering 3:1.
Crossref
Janaki Ramaiah Mekala, Rohil Kumar Kurappalli, PrasannaSrinivasan Ramalingam & Nageswara Rao Moparthi. (2021) N-acetyl l-aspartate and Triacetin modulate tumor suppressor MicroRNA and class I and II HDAC gene expression induce apoptosis in Glioblastoma cancer cells in vitro. Life Sciences 286, pages 120024.
Crossref
Ahmet Kaynak, Harold W. Davis, Subrahmanya D. Vallabhapurapu, Koon Y. Pak, Brian D. Gray & Xiaoyang Qi. (2021) SapC–DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents. Pharmaceuticals 14:11, pages 1193.
Crossref
Leonardo Delello Di Filippo, Juliana Hofstätter Azambuja, Jessyca Aparecida Paes Dutra, Marcela Tavares Luiz, Jonatas Lobato Duarte, Luiza Ribeiro Nicoleti, Sara Teresinha Olalla Saad & Marlus Chorilli. (2021) Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers. European Journal of Pharmaceutics and Biopharmaceutics 168, pages 76-89.
Crossref
Taksim Ahmed, Fuh-Ching Franky Liu, Chungsheng He, Azhar Z. Abbasi, Ping Cai, Andrew M. Rauth, Jeffery T. Henderson & Xiao Yu Wu. (2021) Optimizing the Design of Blood–Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma. Pharmaceutical Research 38:11, pages 1897-1914.
Crossref
Ritu R. Kudarha & Krutika K. Sawant. (2020) Chondroitin sulfate conjugation facilitates tumor cell internalization of albumin nanoparticles for brain-targeted delivery of temozolomide via CD44 receptor-mediated targeting. Drug Delivery and Translational Research 11:5, pages 1994-2008.
Crossref
Shiqi Kong, Xinbo Ge, Xin Li, Zhenbo Liu, Rui Zhang, Ming Yang, Zhenhai Wang & Zhenzhong Li. (2021) SD‐36 promotes growth inhibition and induces apoptosis via suppression of Mcl‐1 in glioma. Journal of Cellular and Molecular Medicine 25:17, pages 8261-8270.
Crossref
Nathalia Müller, Mateus Eugenio, Luciana F. Romão, Jorge Marcondes de Souza, Soniza V. Alves‐Leon, Loraine Campanati & Celso Sant’Anna. (2021) Assessing the antiproliferative effect of biogenic silver chloride nanoparticles on glioblastoma cell lines by quantitative image‐based analysis. IET Nanobiotechnology 15:6, pages 558-564.
Crossref
Ji-Young Yoo, Margaret Yeh, Yin-Ying Wang, Christina Oh, Zhong-Ming Zhao, Balveen Kaur & Tae-Jin Lee. (2021) MicroRNA-138 Increases Chemo-Sensitivity of Glioblastoma through Downregulation of Survivin. Biomedicines 9:7, pages 780.
Crossref
Madineh Mazarei, Pooria Mohammadi Arvejeh, M. R. Mozafari, Pegah Khosravian & Sorayya Ghasemi. (2021) Anticancer Potential of Temozolomide-Loaded Eudragit-Chitosan Coated Selenium Nanoparticles: In Vitro Evaluation of Cytotoxicity, Apoptosis and Gene Regulation. Nanomaterials 11:7, pages 1704.
Crossref
Ritu R. Kudarha & Krutika K. Sawant. (2021) Hyaluronic acid conjugated albumin nanoparticles for efficient receptor mediated brain targeted delivery of temozolomide. Journal of Drug Delivery Science and Technology 61, pages 102129.
Crossref
Shih-Han Chen, Chun-Nun Chao, San-Yuan Chen, Han-Pei Lin, Hsin-Yi Huang & Chiung-Yao Fang. (2021) Flunarizine, a drug approved for treating migraine and vertigo, exhibits cytotoxicity in GBM cells. European Journal of Pharmacology 892, pages 173756.
Crossref
Zafer Sahin, Sevde Nur Biltekin, Leyla Yurttas, Barkin Berk, Yağmur Özhan, Hande Sipahi, Zhan-Guo Gao, Kenneth A. Jacobson & Şeref Demirayak. (2021) Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition. European Journal of Medicinal Chemistry 212, pages 113125.
Crossref
Qingxin Song, Shanxin Peng, Zhiqing Sun, Xueyuan Heng & Xiaosong Zhu. (2021) Temozolomide Drives Ferroptosis via a DMT1-Dependent Pathway in Glioblastoma Cells. Yonsei Medical Journal 62:9, pages 843.
Crossref
Akshay Athavale, Jack Morris, Meg Jardine, Martin Gallagher, Shaundeep Sen, Angus Ritchie & Amanda Y. Wang. (2020) Acute interstitial nephritis and nephrogenic diabetes insipidus following treatment with sulfamethoxazole‐trimethoprim and temozolomide. Nephrology 26:1, pages 12-14.
Crossref
Michelle Zalles, Nataliya Smith, Debra Saunders, Mayra Guzman, Megan Lerner, Kar-Ming Fung, Anish Babu, James Battiste, Junho Chung, Kyusang Hwang, Junyeong Jin & Rheal A Towner. (2021) ELTD1 as a multi-focal target for malignant gliomas: preclinical studies. Neuro-Oncology Advances 3:1.
Crossref
Qianyi Fan, Yuanyuan Liu, Guanhong Cui, Zhiyuan Zhong & Chao Deng. (2021) Brain delivery of Plk1 inhibitor via chimaeric polypeptide polymersomes for safe and superb treatment of orthotopic glioblastoma. Journal of Controlled Release 329, pages 1139-1149.
Crossref
Luiza Steffens, Mabilly Cox Holanda de Barros Dias, Pablo Ricardo Arantes, Jeferson Gustavo Henn, Michael Nugent & Dinara Jaqueline Moura. 2021. Advances and Challenges in Pharmaceutical Technology. Advances and Challenges in Pharmaceutical Technology 355 394 .
Seyed H. Shahcheraghi, Marzieh Lotfi, Mohammad Soukhtanloo, Majid Ghayour-Mobarhan, Hossein Z. Jaliani, Hamid R. Sadeghnia & Ahmad Ghorbani. (2020) Effects of Galbanic Acid on Proliferation, Migration, and Apoptosis of Glioblastoma Cells Through the PI3K/Akt/MTOR Signaling Pathway. Current Molecular Pharmacology 14:1, pages 79-87.
Crossref
Laura Sinatra, Jan J. Bandolik, Martin Roatsch, Melf Sönnichsen, Clara T. Schoeder, Alexandra Hamacher, Andrea Schöler, Arndt Borkhardt, Jens Meiler, Sanil Bhatia, Matthias U. Kassack & Finn K. Hansen. (2020) Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs). Angewandte Chemie International Edition 59:50, pages 22494-22499.
Crossref
Laura Sinatra, Jan J. Bandolik, Martin Roatsch, Melf Sönnichsen, Clara T. Schoeder, Alexandra Hamacher, Andrea Schöler, Arndt Borkhardt, Jens Meiler, Sanil Bhatia, Matthias U. Kassack & Finn K. Hansen. (2020) Hydroxamic Acids Immobilized on Resins (HAIRs): Synthese von Dual‐Target‐HDAC‐Inhibitoren und HDAC‐PROTACs . Angewandte Chemie 132:50, pages 22681-22687.
Crossref
Seung-Hye Choi, SeongShick Ryu, Kyoungmi Sim, Chiman Song, Injae Shin, Seong-Seop Kim, Young-Sun Lee, Jae-Yong Park & Taebo Sim. (2020) Anti-glioma effects of 2-aminothiophene-3-carboxamide derivatives, ANO1 channel blockers. European Journal of Medicinal Chemistry 208, pages 112688.
Crossref
Junyi Tan, Xiaohui Duan, Fang Zhang, Xiaohua Ban, Jiaji Mao, Minghui Cao, Shisong Han, Xintao Shuai & Jun Shen. (2020) Theranostic Nanomedicine for Synergistic Chemodynamic Therapy and Chemotherapy of Orthotopic Glioma. Advanced Science 7:24.
Crossref
Hyeon Ji Kim & Do-Yeon Kim. (2020) Present and Future of Anti-Glioblastoma Therapies: A Deep Look into Molecular Dependencies/Features. Molecules 25:20, pages 4641.
Crossref
Qin Xia, Mengchuan Xu, Pei Zhang, Liqun Liu, Xinyi Meng & Lei Dong. (2020) Therapeutic Potential of Autophagy in Glioblastoma Treatment With Phosphoinositide 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin Signaling Pathway Inhibitors. Frontiers in Oncology 10.
Crossref
Alan Dogan & Horst von Recum. (2020) Engineering selective molecular tethers to enhance suboptimal drug properties. Acta Biomaterialia 115, pages 383-392.
Crossref
Natalia M. Gretskaya, Alina M. Gamisonia, Polina V. Dudina, Stanislav S. Zakharov, Galina Sherstyanykh, Roman Akasov, Sergey Burov, Igor V. Serkov, Mikhail G. Akimov, Vladimir V. Bezuglov & Elena Markvicheva. (2020) Novel bexarotene derivatives: Synthesis and cytotoxicity evaluation for glioma cells in 2D and 3D in vitro models. European Journal of Pharmacology 883, pages 173346.
Crossref
Yingxiao Cao, Shiqi Kong, Yuling Xin, Yan Meng, Shuling Shang & Yanhui Qi. (2020) Lestaurtinib potentiates TRAIL‐induced apoptosis in glioma via CHOP‐dependent DR5 induction. Journal of Cellular and Molecular Medicine 24:14, pages 7829-7840.
Crossref
Adomas Bunevicius, Nathan Judson McDannold & Alexandra J Golby. (2020) Focused Ultrasound Strategies for Brain Tumor Therapy. Operative Neurosurgery 19:1, pages 9-18.
Crossref
Chengrui Yan, Xiangyi Kong, Shun Gong, Fengrui Liu & Yuanli Zhao. (2020) Recent advances of the regulation roles of MicroRNA in glioblastoma. International Journal of Clinical Oncology 25:7, pages 1215-1222.
Crossref
Mehrdad Khoshnevis, Claude Carozzo, Richard Brown, Manuel Bardiès, Catherine Bonnefont-Rebeix, Sara Belluco, Christophe Nennig, Lionel Marcon, Olivier Tillement, Hélène Gehan, Cédric Louis, Ilyes Zahi, Thierry Buronfosse, Thierry Roger & Frédérique Ponce. (2020) Feasibility of intratumoral 165Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipig. PLOS ONE 15:6, pages e0234772.
Crossref
Guangyong Chen, Zhuo Chen & Hang Zhao. (2020) MicroRNA‐155‐3p promotes glioma progression and temozolomide resistance by targeting Six1. Journal of Cellular and Molecular Medicine 24:9, pages 5363-5374.
Crossref
Tarielle Jones, Bisheng Zhang, Stephano Major & Antonio Webb. (2019) All‐trans retinoic acid eluting poly(diol citrate) wafers for treatment of glioblastoma. Journal of Biomedical Materials Research Part B: Applied Biomaterials 108:3, pages 619-628.
Crossref
Zhi-Qin Liu, Jing-Jing Ren, Jun-Long Zhao, Jian Zang, Qian-Fa Long, Jing-Jing Du, Xiao-Tao Jia, Nai-Bing Gu, Zheng-Li Di, Yi-Hua Qian & San-Zhong Li. (2020) MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7. Scientific Reports 10:1.
Crossref
Michelle Zalles, Nataliya Smith, Debra Saunders, Tanvi Saran, Lincy Thomas, Rafal Gulej, Megan Lerner, Kar-Ming Fung, Junho Chung, Kyusang Hwang, Junyeong Jin, James Battiste & Rheal A. Towner. (2020) Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model. Translational Oncology 13:3, pages 100737.
Crossref
Rencui Quan, Huaqing Zhang, Zihuang Li & Xianming Li. (2020) Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide. Medicine 99:2, pages e18591.
Crossref
Rebeca Piatniczka Iglesia, Camila Felix de Lima Fernandes, Bárbara Paranhos Coelho, Mariana Brandão Prado, Maria Isabel Melo Escobar, Gustavo Henrique Doná Rodrigues Almeida & Marilene Hohmuth Lopes. (2019) Heat Shock Proteins in Glioblastoma Biology: Where Do We Stand?. International Journal of Molecular Sciences 20:22, pages 5794.
Crossref
Xiao Li, Fenli Shao, Jian Sun, Ke Du, Yang Sun & Fude Feng. (2019) Enhanced Copper–Temozolomide Interactions by Protein for Chemotherapy against Glioblastoma Multiforme. ACS Applied Materials & Interfaces 11:45, pages 41935-41945.
Crossref
Daniel A. Rodriguez de Anda, Nareg Ohannesian, Karen S. Martirosyan & Sue Anne Chew. (2019) Effects of solvent used for fabrication on drug loading and release kinetics of electrosprayed temozolomide‐loaded PLGA microparticles for the treatment of glioblastoma. Journal of Biomedical Materials Research Part B: Applied Biomaterials 107:7, pages 2317-2324.
Crossref
Diogo S. Pellosi, Leonardo B. Paula, Maryanne T. de Melo & Antonio C. Tedesco. (2019) Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy. Molecular Pharmaceutics 16:3, pages 1009-1024.
Crossref
Tovi Shapira-Furman, Riccardo Serra, Noah Gorelick, Marisol Doglioli, Valentina Tagliaferri, Arba Cecia, Michael Peters, Awanish Kumar, Yakir Rottenberg, Robert Langer, Henry Brem, Betty Tyler & Abraham J. Domb. (2019) Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer. Journal of Controlled Release 295, pages 93-101.
Crossref
Alessandra Brunetti, Oliviero Marinelli, Maria Beatrice Morelli, Romilde Iannarelli, Consuelo Amantini, Domenico Russotti, Giorgio Santoni, Filippo Maggi & Massimo Nabissi. (2019) Isofuranodiene synergizes with temozolomide in inducing glioma cells death. Phytomedicine 52, pages 51-59.
Crossref
Matthew A. Taylor, Bhaskar C. Das & Swapan K. Ray. (2018) Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma. Apoptosis 23:11-12, pages 563-575.
Crossref
Edouard Alphandéry. (2018) Glioblastoma Treatments: An Account of Recent Industrial Developments. Frontiers in Pharmacology 9.
Crossref
Simona Sestito, Massimiliano Runfola, Marco Tonelli, Grazia Chiellini & Simona Rapposelli. (2018) New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective. Frontiers in Pharmacology 9.
Crossref
Ying Pang, Yanxin Lu, Veronika Caisova, Yang Liu, Petra Bullova, Thanh-Truc Huynh, Yiqiang Zhou, Di Yu, Zdenek Frysak, Igor Hartmann, David Taïeb, Karel Pacak & Chunzhang Yang. (2018) Targeting NAD+/PARP DNA Repair Pathway as a Novel Therapeutic Approach to SDHB -Mutated Cluster I Pheochromocytoma and Paraganglioma . Clinical Cancer Research 24:14, pages 3423-3432.
Crossref
María González-Tablas, Inês Crespo, Ana Luísa Vital, Álvaro Otero, Ana Belén Nieto, Pablo Sousa, María Carmen Patino-Alonso, Luis Antonio Corchete, Hermínio Tão, Olinda Rebelo, Marcos Barbosa, Maria Rosário Almeida, Ana Filipa Guedes, María Celeste Lopes, Pim J. French, Alberto Orfao & María Dolores Tabernero. (2018) Prognostic stratification of adult primary glioblastoma multiforme patients based on their tumor gene amplification profiles. Oncotarget 9:46, pages 28083-28102.
Crossref
L. Nam, C. Coll, L. Erthal, C. de la Torre, D. Serrano, R. Martínez-Máñez, M. Santos-Martínez & E. Ruiz-Hernández. (2018) Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme. Materials 11:5, pages 779.
Crossref
René Rocha, Ángelo Torres, Karina Ojeda, Daniel Uribe, Dellis Rocha, José Erices, Ignacio Niechi, Pamela Ehrenfeld, Rody San Martín & Claudia Quezada. (2018) The Adenosine A3 Receptor Regulates Differentiation of Glioblastoma Stem-Like Cells to Endothelial Cells under Hypoxia. International Journal of Molecular Sciences 19:4, pages 1228.
Crossref
Chao Xiang, Yunfei Zha & Qianxue Chen. (2018) Effect of radiotherapy and chemotherapy on levels of serum S100B, IL-6, and IL-17 in patients with malignant glioma. European Journal of Inflammation 16, pages 205873921880432.
Crossref
Adrienne C. Scheck. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 87 104 .
José M. Duhart, Lucila Brocardo, Carlos S. Caldart, Luciano Marpegan & Diego A. Golombek. (2017) Circadian Alterations in a Murine Model of Hypothalamic Glioma. Frontiers in Physiology 8.
Crossref
Jason Choi, Alexandre Moquin, Enzo Bomal, Li Na, Dusica Maysinger & Ashok Kakkar. (2017) Telodendrimers for Physical Encapsulation and Covalent Linking of Individual or Combined Therapeutics. Molecular Pharmaceutics 14:8, pages 2607-2615.
Crossref
Weilin Xu, Tao Li, Liansheng Gao, Jingwei Zheng, Anwen Shao & Jianmin Zhang. (2017) Efficacy and safety of long-term therapy for high-grade glioma with temozolomide: A meta-analysis. Oncotarget 8:31, pages 51758-51765.
Crossref
Nichola Cruickshanks, Ying Zhang, Fang Yuan, Mary Pahuski, Myron Gibert & Roger Abounader. (2017) Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma. Cancers 9:12, pages 87.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.